We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Clene Inc
10 own
8 watching
Current Price
$1.62
$0.07
(4.52%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
102.94M
52-Week High
5.13
52-Week Low
0.87
Average Volume
0.07M
Dividend Yield
--
P/E Ratio
--
Market Capitalization102.94M52-Week High5.1352-Week Low0.87Average Volume0.07MDividend Yield--P/E Ratio--What does the Clene Inc do?
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain s energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Read More
How much money does Clene Inc make?
News & Events about Clene Inc.
Globe Newswire
23days ago
SALT LAKE CITY, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, Clene) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company today announced that it will participate in Renmark Financial Communications Inc.s ...
Globe Newswire
1month ago
Funding Demonstrates Importance of Working with Private Sector to Improve Lives of Marylanders, says Governor HoganSALT LAKE CITY, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries Clene) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage...
Globe Newswire
2 months ago
CNM-Au8 demonstrated low contrast vision improvement and global neurological improvement (low contrast vision, cognition, upper extremity function, and walking speed) in stable MS patients as adjunct to background immunomodulating disease modifying therapies (DMTs)No approved MS DMTs have shown ...
Globe Newswire
2 months ago
Secondary survival endpoint for the CNM-Au8 30 mg dose investigated in the Healey ALS Platform Trial demonstrated a >90% reduction in the risk of death or death equivalent (permanently assisted ventilation) and risk of death alone at 24 weeks. This survival benefit was consistent with prior results ...
Zolmax
2 months ago
Clene Inc. (NASDAQ:CLNN Get Rating) Director David J. Matlin purchased 2,871,287 shares of the stock in a transaction dated Wednesday, November 2nd. The shares were purchased at an average price of $1.01 per share, with a total value of $2,899,999.87. Following the transaction, the director now ...
Frequently Asked Questions
Frequently Asked Questions
What is Clene Inc share price today?
Can Indians buy Clene Inc shares?
How can I buy Clene Inc shares from India?
Can Fractional shares of Clene Inc be purchased?
What are the documents required to start investing in Clene Inc stocks?
What is today’s traded volume of Clene Inc?
What is today’s market capitalisation of Clene Inc?
What is the 52-Week High and Low Range of Clene Inc?
What percentage is Clene Inc down from its 52-Week High?
What percentage is Clene Inc up from its 52-Week Low?
Current Price
$1.62
$0.07
(4.52%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.